New class of small molecules show promise against memory loss

TUCSON, Ariz. — March 20, 2013 — BIO5 Oro Valley today announced a collaboration with the Translational Genomics Research Institute (TGen) to develop new therapies for the treatment of Alzheimer’s and other neurodegenerative diseases.

Read the press release here.
(Link will open in a new window)

. .